BlogNews and press

Alveofit has won the Vedanta Spark 2.0 competition for the theme ‘Zero Harm’

1 min readUpdated 11 September 2025

Alveofit® has won the Vedanta_Spark 2.0 competition for the theme ‘Zero Harm’

We are delighted to announce that alveofit® has won the Vedanta Spark 2.0 competition for the theme 'Zero Harm'. This is a tremendous achievement and a testament to the hard work and dedication of our team. The Vedanta Spark 2.0 competition is a global contest that recognizes and rewards organizations that are making a positive impact in the world. The 'Zero Harm' theme is particularly close to our heart, as it is something that we are passionate about at alveofit®. We believe that every workplace should be a safe and healthy environment for everyone involved, and we are committed to promoting and championing this belief. We will continue to work hard to make a difference in the world, and we are honored to have been recognized for our efforts. alveofit® will be executing pilot projects to validate their technologies & drive Environmental, Social, and Governance outcomes for Vedanta. alveofit® will be able to demonstrate the potential of its technology to drive real-world impact and create value for both Vedanta and alveofit®. Vedanta Spark is a corporate innovation, accelerator & venture program with a global reach, striving to enable startups to create large-scale impact through the use of transformative & sustainable technologies. The program is in partnership with the group companies of Vedanta - diversified energy & resources conglomerate with operations on 3 continents. We are thankful to the Vedanta Spark 2.0 team for the opportunity to participate in this exciting program. And We look forward to continuing to work with Vedanta and contributing to the success of the company.

See alveofit in your clinic.

A 30-minute demo of oscillometry, spirometry and alveoConnect, on your own patients' workflow.

Book a demo
  1. Acquisition time of 15–30 seconds of tidal breathing per recording, from the alveoflow FOT System specification. Applies to alveoflow Pro and alveoflow Neo.
  2. FHIR R4 and HL7 v2 export from the alveoflow FOT System specification. ABDM integration supported.
  3. CDSCO Class B under MDR 2017. ISO 13485 and MDSAP as stated on alveo.fit. alveoflow: US 510(k) submission pending; not cleared for sale in the United States. alveoair is US FDA 510(k) cleared (K222525, August 2023).
  4. Screens show example data and do not represent a real patient. Interpretation is the responsibility of the treating clinician.